BlackRock’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $117M | Sell |
|
|||||
|
2025
Q2 | $77.2M | Sell |
|
|||||
|
2025
Q1 | $76.9M | Sell |
|
|||||
|
2024
Q4 | $110M | Buy |
|
|||||
|
2024
Q3 | $109M | Buy |
|
|||||
|
2024
Q2 | $62.1M | Buy |
|
|||||
|
2024
Q1 | $66.8M | Buy |
|
|||||
|
2023
Q4 | $74.6M | Buy |
|
|||||
|
2023
Q3 | $45.9M | Sell |
|
|||||
|
2023
Q2 | $74.1M | Buy |
|
|||||
|
2023
Q1 | $70.6M | Buy |
|
|||||
|
2022
Q4 | $80.7M | Buy |
|
|||||
|
2022
Q3 | $40.7M | Buy |
|
|||||
|
2022
Q2 | $16.5M | Buy |
|
|||||
|
2022
Q1 | $2.83M | Sell |
|
|||||
|
2021
Q4 | $3.03M | Buy |
|
|||||
|
2021
Q3 | $836K | Buy |
|
|||||
|
2021
Q2 | $919K | Buy |
|
|||||
|
2021
Q1 | $516K | Hold |
|
|||||
|
2020
Q4 | $508K | Sell |
|
|||||
|
2020
Q3 | $426K | Hold |
|
|||||
|
2020
Q2 | $610K | Buy |
|
|||||
|
2020
Q1 | $196K | Buy |
|
|||||
|
2019
Q4 | $199K | Sell |
|
|||||
|
2019
Q3 | $304K | Hold |
|
|||||
|
2019
Q2 | $853K | Sell |
|
|||||
|
2019
Q1 | $3.93M | Sell |
|
|||||
|
2018
Q4 | $4.42M | Buy |
|
|||||
|
2018
Q3 | $7.88M | Buy |
|
|||||
|
2018
Q2 | $8.93M | Buy |
|
|||||
|
2018
Q1 | $5.67M | Buy |
|
|||||
|
2017
Q4 | $6M | Buy |
|
|||||
|
2017
Q3 | $5.03M | Buy |
|
|||||
|
2017
Q2 | $6.67M | Buy |
|
|||||
|
2017
Q1 | $1K | Buy |
|